NCT05510830Not yet recruiting
Diagnostic Cervical Conization for Persistent Infection or Integration of HPV
A Study of the Value of Diagnostic Cervical Conization for Persistent Infection or Integration of Human Papillomavirus
Source: ClinicalTrials.gov · Last updated 8 Sept 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
For the patients with cervical persistent infection or integration of HPV, we has designed a program to perform cervical conization for certain patients to earlier and better diagnose and cure the diseases of HPV infection and related cervical intraepithelial neoplasia/cancer.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 16 Aug 2022
- Start date
- Oct 2022
- Primary completion date
- Jan 2028
- Lead sponsor
- Tongji Hospital
- Diseases
- Cervical cancer
- NCT number
- NCT05510830
What you commit to
- Study type: Interventional
- Planned participants: 250
- From Oct 2022 to the primary completion date, Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- The patients are suffering malignant tumors of other system and have not been cured.
- The patients' health will be severely harmed by the colposcopy and cervical conization due to some circumstances such as severe insufficiency of liver and kidney function, blood diseases and acute inflammation of other systems.
Other
- Pregnant women.
- Vaginal intraepithelial neoplasia is highly suspected by colposcopy and pathological examinations.
- There is acute inflammation of the lower genital or anal tract.
Who the study is looking for
- The patients are referred to colposcopy and biopsy examinations due to abnormal cervical screening results with no precancerous lesions discovered by pathology.
- The cervical precancerous lesions are highly suspected by clinicians with one or more following risk factors:
- The course of HPV type 16/18 persistent infection is more than two years.
- The integration reads of HPV is more than 15.
- The impression of colposcopy indicates precancerous lesions.
- The cervical TCT indicates ASC-H/HSIL/SCC/AGC-FN/AIS/AC.
Age in the registry: 25 years to 70 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.